Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
05/2010
05/27/2010US20100129425 Vaginal delivery system for mirtazapine
05/27/2010US20100129423 Device made at least partially of n-acetylchitosan with controlled biodissolution
05/27/2010US20100129418 Method of inducing negative chemotaxis using an ellagitannin or gallotannin
05/27/2010US20100129414 Bioactive Agent Delivery Using Liposomes in Conjunction With Stent Deployment
05/27/2010US20100129413 Method of treating and preventing viral infections
05/27/2010US20100129296 Extract of trigonella foenum-graecum
05/27/2010US20100129295 Compositions for preventing and/or treating gingivitis
05/27/2010US20100129294 Nattokinase for degrading and reducing amyloid fibrils assoicated with alzheimer's disease, prion diseases and other amyloidoses
05/27/2010DE202009015203U1 Topisch anwendbares Alaun enthaltendes Mittel Topical application of alum-containing agent
05/27/2010CA2781597A1 Pharmaceutical articles coated with lubricious coatings
05/27/2010CA2781591A1 Implantable liposome embedded matrix composition, uses thereof, and polycaprolactone praticles as scaffolds for tissue regeneration
05/27/2010CA2744377A1 Directly compressible high functionality granular dibasic calcium phosphate based co-processed excipient
05/27/2010CA2744211A1 Wet granulation of tenofovir, emtricitabine and efavirenz
05/27/2010CA2744207A1 Polyvalent rna-nanoparticle compositions
05/27/2010CA2744150A1 Novel form of administering osteogenic protein complexes
05/27/2010CA2744142A1 Directly compressible granular microcrystalline cellulose based excipient, manufacturing process and use thereof
05/27/2010CA2744048A1 Single-time vaccines
05/27/2010CA2743967A1 Homeopathic composition comprising hypericum perforatum extract and essential oils for the treatment of neuropathic pain
05/27/2010CA2743959A1 Liposomal composition for convection-enhanced delivery to the central nervous centre
05/27/2010CA2743261A1 Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
05/27/2010CA2743260A1 Intravaginal delivery system and process for manufacturing it
05/27/2010CA2741041A1 Prolonged release formulations comprising an 2-oxo-1-pyrrolidine derivative
05/27/2010CA2741038A1 Prolonged release formulations comprising an 2-oxo-1-pyrrolidine derivate
05/27/2010CA2738732A1 Pharmaceutical composition of a potent hcv inhibitor for oral administration
05/27/2010CA2738616A1 Aerosol formulation for the inhalation of beta agonists
05/27/2010CA2737045A1 Therapeutic protein formulations
05/27/2010CA2708334A1 Process for recovering florfenicol from pharmaceutical compositions
05/26/2010EP2189475A2 Fibroblast growth factor-like polypeptides
05/26/2010EP2189163A1 A composition for treatment of diabetes mellitus and a preparation and an use thereof
05/26/2010EP2189162A1 Methods for the treatment of cellular proliferative disorders
05/26/2010EP2189156A1 Lys-Pro and Lys-Pro-Thr for the manufacture of a cosmetic composition
05/26/2010EP2189154A1 Effervescent tablets and mouth-soluble granulates of S-adenosyl methionine and process for the preparation thereof
05/26/2010EP2189153A2 Article of manufacture used in contact with human body surfaces
05/26/2010EP2187980A1 Hydrogel polymeric compositions and methods
05/26/2010EP2187968A2 Thermo-kinetic mixing for pharmaceutical applications
05/26/2010EP2187932A1 Protein formulations comprising gdf-5 in aqueous acidic solution
05/26/2010EP2187886A1 Stable pharmaceutical composition comprising a hydrosoluble vinflunine salt
05/26/2010EP2187881A1 Powdered medicament for nasal delivery of ascorbic acid for reducing apomorphine induced toxicity to ciliated tissue
05/26/2010EP2187877A2 Aqueous-core lipid nanocapsules for encapsulating hydrophilic and/or lipophilic molecules
05/26/2010EP2187875A1 Ph-dependent controlled release pharmaceutical composition for non-opioids with resistance against the influence of ethanol
05/26/2010EP2187874A2 Sustained release compositions of trimetazidine and process for preparation thereof
05/26/2010EP2187873A2 Abuse resistant drugs, method of use and method of making
05/26/2010EP2187872A1 Extended release compositions comprising mycophenolate sodium and processes thereof
05/26/2010EP2187871A1 Mixtures comprising pellitorin and uses thereof
05/26/2010EP2187870A1 Method of producing a system for delivering active ingredients of plant origin
05/26/2010EP2187869A1 Improved platinum drug formulations
05/26/2010EP2187867A1 Injectable pharmaceutical formulation of taxoids
05/26/2010EP2187866A2 Dexamethasone formulations in a biodegradable material
05/26/2010EP2187759A1 Erythritol-based hard coatings
05/26/2010EP2187743A2 Formulations for treatment of ocular diseases or conditions
05/26/2010EP1605971B1 Immunogenic composition and methods
05/26/2010EP1541155B1 Material for formation of carbon dioxide external preparation
05/26/2010EP1424998B1 Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies
05/26/2010EP1132383B1 Novel agarofuan derivatives, their preparation, pharmaceutical composition containing them and their use as medicine
05/26/2010CN201481825U cataplasma
05/26/2010CN1985900B Colon-targeting oral compound rubarb preparation
05/26/2010CN1980646B Softgel encapsulated pharmaceutical compositions comprising concentrated active ingredients
05/26/2010CN1969965B Ointment for treating bone injuries
05/26/2010CN1969814B Nasal administered preparation of melatonin
05/26/2010CN1965898B Compound capsule of red sage root and method for preparing same
05/26/2010CN1961961B A pharmaceutical formulation and preparation process thereof
05/26/2010CN1960736B Anti-infectious hydrogel compositions
05/26/2010CN1951494B Compound Chinese medicinal preparation for treating affection of external wind and cold and preparation method thereof
05/26/2010CN1951483B Hybrid safflower oil and preparation method thereof
05/26/2010CN1943565B Biological degradable nano medicinal capsule with MRI tracer effect and its preparing method
05/26/2010CN1942175B Sustained-release tramadol formulations with 24-hour efficacy
05/26/2010CN1935277B Preparation for the prophylaxis of restenosis
05/26/2010CN1935211B Medicinal composition for treating cerebral ischemia
05/26/2010CN1931245B Medicine for treating gouty arthritis and its preparation process and application
05/26/2010CN1913878B Transdermal delivery of hormones without the need of penetration enhancers
05/26/2010CN1899456B Pile ointment
05/26/2010CN1899370B Compound calyx melo extract tablet
05/26/2010CN1895546B Lycium chinensis polyose medicinal composition with therapeutic and health-care functions
05/26/2010CN1895353B Preparation of compound Danshen tablets
05/26/2010CN1893932B Microemulsion preconcentrate comprising a renin inhibitor
05/26/2010CN1893916B Cosmetic and dermatologic oxygen carrier system
05/26/2010CN1879745B A veterinary Chinese medicinal powder for treating avian viral disease
05/26/2010CN1879711B A Chinese medicinal composition for treating gastric disease, its preparation process and detection method
05/26/2010CN1875022B Tocopherol-modified therapeutic drug compounds
05/26/2010CN1870982B Composition containing reduced coenzyme q
05/26/2010CN1868530B Traditional Chinese medicine composition for treating cyclomastopathy and its preparation method
05/26/2010CN1856318B Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same
05/26/2010CN1853654B Oral preparation containing pearl and vitamine
05/26/2010CN1840002B Chinese medicinal preparation for treating chronic obstructive lung disease (COPD) and preparation method thereof
05/26/2010CN1832751B Periodontal disease therapeutic and/or preventive composition
05/26/2010CN1827107B Substained analgesia achieved with buprenorphine
05/26/2010CN1816626B Antisense oligonucleotide having anticancerous activity
05/26/2010CN1810282B Soft black bone chicken and white phoenix capsule and its preparation process and quality control method
05/26/2010CN1803189B Use of neurotoxin therapy for treatment of urologic and related disorders
05/26/2010CN1803144B Pharmaceutical composition containing clofibrate compound and B family vitamin
05/26/2010CN1799622B Mind-tranquilizing brain-replenishing soft capsule, its preparation process and quality control method
05/26/2010CN1799559B Chinese medicinal gel formulation, its preparation process and quality control method
05/26/2010CN1799557B Chinese medicinal gel formulation, its preparation process and quality control method
05/26/2010CN1794976B Dietary supplement and method for the treatment and prevention of digestive tract ulcers in equines and other animals
05/26/2010CN1781545B Method for extracting herbal medicine
05/26/2010CN1771912B Orally taken nanometer protein polypetide composite nano-particle and its preparation
05/26/2010CN1764468B Skin protecting composition
05/26/2010CN1764439B Process for the production of cross-linked gelatin beadlets
05/26/2010CN1758920B Cystitis treatment with high dose chondroitin sulfate
05/26/2010CN1758899B Dosage form having a saccharide matrix